These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1178742)

  • 41. [Use of v. Ardenne's vibrator in pharmaceutical practice].
    Baumgart G
    Pharm Prax; 1970; 3():54-6. PubMed ID: 5430537
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of small-scale preparation techniques on diffusion of salicylic acid from various ointment bases.
    Whitworth CW; Asker AF
    J Pharm Sci; 1974 Oct; 63(10):1618-20. PubMed ID: 4436799
    [No Abstract]   [Full Text] [Related]  

  • 43. [Progress in galenicals (1962-1964)].
    Chalabala M; Malý J; Zácek H
    Pharmazie; 1966 Feb; 21(2):73-95. PubMed ID: 4861050
    [No Abstract]   [Full Text] [Related]  

  • 44. Sterile ophthalmic ointment and suspension manufacturing.
    Abshire R; Cash P
    J Parenter Sci Technol; 1986; 40(3):97-9. PubMed ID: 3746580
    [No Abstract]   [Full Text] [Related]  

  • 45. [The sterility of non-injectable pharmaceutical products].
    Sekules G; Maragliano E
    Boll Chim Farm; 1969 May; 108(5):273-91. PubMed ID: 5806821
    [No Abstract]   [Full Text] [Related]  

  • 46. [Advances in pharmaceutical technology in 1966-1967. II. Drugs and pharmaceutical preparations].
    Chalabala M; Malý J; Burelová A; Starha L; Heliová M; Rak J; Rehula A
    Cesk Farm; 1968 Nov; 17(9):450-61. PubMed ID: 4888356
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hydrogen perioxide ointment in pharmacy prescription].
    Czerwenka G
    Pharm Prax; 1968; 1():23. PubMed ID: 5731386
    [No Abstract]   [Full Text] [Related]  

  • 48. [Dispersing effect of dimexide during preparation of suspension ointments].
    Murav'ev IA; Gorbunova TV
    Farmatsiia; 1970; 19(4):26-30. PubMed ID: 5488014
    [No Abstract]   [Full Text] [Related]  

  • 49. [Progress in drug technology in the years 1968 and 1969].
    Chalabala M; Malý J; Burelová A
    Cesk Farm; 1970 Nov; 19(9):332-60. PubMed ID: 4926371
    [No Abstract]   [Full Text] [Related]  

  • 50. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
    Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
    Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of ointments with salicylic acid by tests in vivo and in vitro].
    Hanzelová H; Gruntovà Z; Zathurecký L; Mandák M; Petrejciková A
    Cesk Farm; 1973 Sep; 22(7):296-300. PubMed ID: 4742504
    [No Abstract]   [Full Text] [Related]  

  • 52. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Apr; 32(2):41-4. PubMed ID: 3453353
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity.
    Zhao L; Fang L; Xu Y; Zhao Y; He Z
    Int J Pharm; 2008 Mar; 352(1-2):92-103. PubMed ID: 18053661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Corticoid ointments with salicylic acid components in ambulatory practice].
    Sedlmaier R
    Z Allgemeinmed; 1972 Mar; 48(8):391-5. PubMed ID: 5033206
    [No Abstract]   [Full Text] [Related]  

  • 55. [Contributions to the liberation of drugs from suspension ointments. Part 19: Studies on the interactions of hydroxyquinoline (salts) with ointment components (author's transl)].
    Heber B; Horsch W
    Pharmazie; 1982 Apr; 37(4):277-9. PubMed ID: 7100252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factorial designs in pharmaceutical preformulation studies. I. Evaluation of the application of factorial designs to a stability study of drugs in suspension form.
    Waltersson JO
    Acta Pharm Suec; 1986; 23(3):129-38. PubMed ID: 3766158
    [No Abstract]   [Full Text] [Related]  

  • 57. Detection and determination of salicylic acid impurity in aspirin tablet formulations' by high performance liquid chromatography.
    Salako Q; Fadiran EO; Thomas WO
    Afr J Med Med Sci; 1989 Sep; 18(3):215-8. PubMed ID: 2551162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anthralin-salicylic acid therapy of psoriasis. Cignolin-salicylic acid-vaseline treatment and Lasan paste in a right-left comparison].
    Runne U
    Hautarzt; 1974 Apr; 25(4):199-200. PubMed ID: 4848053
    [No Abstract]   [Full Text] [Related]  

  • 59. [Blood salicylates in children treated with ointments containing salicylic acid].
    Najbrt V
    Cesk Dermatol; 1973 Jun; 48(3):179-83. PubMed ID: 4725885
    [No Abstract]   [Full Text] [Related]  

  • 60. [Serum levels of salicylic acid in patients with psoriasis treated with 10% salicylic acid ointment].
    Zgrzybłowski A; Paradecki W; Przybyła L
    Przegl Dermatol; 1990; 77(1):20-4. PubMed ID: 2200078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.